News
The sports therapy business offers a lot of opportunities. In fact, there’s no denying that sports therapy is a rewarding and prosperous industry. As a sports therapist, your job is to help people ...
The transaction provides Abbott with a complementary solution for treating vascular disease. CSI’s leading atherectomy system prepares vessels for angioplasty or stenting to restore blood flow ...
B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams all at once by using an external ...
Experts Publish Consensus on CT for Prosthetic Heart Valve Assessment. The consensus document was jointly published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of ...
florida / new york. 561.316.3330; home; about. press releases; editorial; advertise; device news ...
The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors. Materna Medical, Inc., a leading ...
The new 133,500-square-foot headquarters at 12001 Exit 5 Parkway will house an advanced pharmacy featuring category III, 503A/503B compounding capabilities alongside integrated telemedicine services ...
Experts from multiple medical societies have published a consensus document to provide guidance on how best to use cardiac CT for prosthetic heart valve assessment. The consensus document was jointly ...
Cloud-based solution monitors temperature and humidity of refrigerators and regulated rooms with real-time alerts to ensure the safety and effectiveness of medications and biologicals Kontakt.io, the ...
The company holds 29 issued patents worldwide, covering key structural innovations in Left Atrial Appendage Occlusion (LAAO) technology, including implant design and conformability features. Conformal ...
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program. Partnership Combines VERAXA’s Proprietary ADC Technology with OmniAb’s Antibody ...
The launch marks a significant step in Seed’s evolution from a DTC disruptor to a leading omnichannel brand, amplifying its strategy to make clinically validated microbiome science accessible wherever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results